Literature DB >> 8199749

Sample size considerations for assessing individual bioequivalence based on the method of tolerance intervals.

J D Esinhart1, V M Chinchilli.   

Abstract

This is the consideration of sample sizes for assessing individual bioequivalence based on the use of tolerance intervals. The sample size procedures discussed include a direct distribution-free method, indirect parametric method and a direct parametric method. Design considerations are discussed based on the results of the direct parametric method. Tables are provided for easy access of results.

Mesh:

Year:  1994        PMID: 8199749

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  3 in total

Review 1.  Content uniformity and dose uniformity: current approaches, statistical analyses, and presentation of an alternative approach, with special reference to oral inhalation and nasal drug products.

Authors:  Roger L Williams; Wallace P Adams; Guirag Poochikian; Walter W Hauck
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Study of the applicabilty of content uniformity and dissolution variation test on ropinirole hydrochloride tablets.

Authors:  Edina Vranić; Alija Uzunović
Journal:  Bosn J Basic Med Sci       Date:  2008-05       Impact factor: 3.363

3.  Individual bioequivalence. New concepts in the statistical assessment of bioequivalence metrics. FDA Individual Bioequivalence Working Group.

Authors:  R N Patnaik; L J Lesko; M L Chen; R L Williams
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.